Symposia: Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Bleeding and Clotting, Adult, Autoimmune disorders, Epidemiology, Clinical Research, Platelet disorders, Genetic Disorders, Genomics, Bioinformatics, Health outcomes research, Health disparities research, Pediatric, Diversity, Equity, and Inclusion (DEI), Diseases, Thrombocytopenias, Immune Disorders, Real-world evidence, Thrombotic disorders, Treatment Considerations, Biological therapies, Registries, Survivorship, Monoclonal Antibody Therapy, Biological Processes, Technology and Procedures, Study Population, Human, Imaging, Omics technologies
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Bleeding and Clotting, Adult, Autoimmune disorders, Epidemiology, Clinical Research, Platelet disorders, Genetic Disorders, Genomics, Bioinformatics, Health outcomes research, Health disparities research, Pediatric, Diversity, Equity, and Inclusion (DEI), Diseases, Thrombocytopenias, Immune Disorders, Real-world evidence, Thrombotic disorders, Treatment Considerations, Biological therapies, Registries, Survivorship, Monoclonal Antibody Therapy, Biological Processes, Technology and Procedures, Study Population, Human, Imaging, Omics technologies
Saturday, December 7, 2024: 12:00 PM-1:30 PM
Room 30
(San Diego Convention Center)
Moderators:
Konstantine Halkidis, MD, PhD, University of Kansas Medical Center
and
Kylee L Martens, MD, Oregon Health & Science University
Disclosures:
No relevant conflicts of interest to declare.
This oral abstract session will cover new developments in thrombotic thrombocytopenic purpura (TTP) including novel treatment approaches for congenital and immune TTP and critical issues that emerge during TTP survivorship.
12:00 PM
12:15 PM
12:30 PM
12:45 PM
1:00 PM
1:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH